IMNN - Rega marang bathi mangsa ngarep imunon.com
Imunon, Inc. (IMNN) is pursuing expansion by scaling its IMNN-001 DNA therapy to combat oncology. Management's efforts to treat ovarian cancer are supported by the company's forward P/E, where the value 0.00 reflects the metric's balance. The dynamics of this indicator link the strategy to real market expectations, highlighting the potential of innovative products currently in the clinical trial phase.
Rincian analitis lan laporan data perusahaan Celsion Corporation (IMNN)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Imunon, Inc.|IMNN - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Imunon, Inc.|IMNN - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Imunon Inc|IMNN - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Imunon|Rasio cepet imunon.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
IMNN - Asil keuangan resik|Bathi sing dikarepake Imunon, Inc.|IMNN - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Imunon, Inc.|IMNN - Rasio P/E diaturake wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Imunon Inc|IMNN - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Imunon|IMNN - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan imunon.com|IMNN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Imunon, Inc.
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:Imunon
Imunon, Inc. (IMNN) high clinical trial expenditures and the protection of intellectual property via the Plasmids platform create a significant barrier to entry for competitors. The ratio of current market capitalization to projected earnings per share allows for a valuation of future revenues, while the company's forward P/E dynamics help investors determine the premium paid for potential technological monopoly in oncology.
Pesaing Imunon, Inc.
Rega marang bathi mangsa ngarep Tempus Labs (TEM)|Qiagen NV - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Ionis Pharma IONS|Repligen Inc. (RGEN) - Rasio prakiraan rega marang bathi|RNA - Rega marang bathi mangsa ngarep|CRSP (crisprtx.com) - Rasio rega marang bathi mangsa ngarep|WGS (GeneDx) - Prakiraan rega marang bathi|Ultragenyx Pharmaceutical Inc. - Pangali mangsa ngarep rega marang bathi|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|Sarepta Corp (SRPT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Twist Bioscience (TWST)|10xgenomics.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E NTLA (Intellia Therapeutics, Inc.)|STOK - Prakiraan rega marang bathi|BLFS: Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi Wave Pharma WVE|MAZE: Pangali Forward P/E|SION - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Prime Medicine|Prakiraan rega marang bathi Taysha Gene Therapies Inc (TSHA)|Rega marang bathi mangsa ngarep uniQure Corp (QURE)|MeiraGTx Corp - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep REGENXBIO Inc. RGNX|SLDB: Rasio rega marang bathi mangsa ngarep|Ocugen - Pangali Forward P/E|PACB (Pacific Biosciences of California, Inc.) - Rasio rega marang bathi mangsa ngarep|Benitec (BNTC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep DSGN|RCKT (Rocket Pharmaceuticals) - Pangali Forward P/E|Pangali Forward P/E 4dmoleculartherapeutics.com|Pangali Forward P/E LXEO|Kapitalisasi marang proyeksi bathi korrobio.com|Rega marang bathi mangsa ngarep Editas EDIT|SLN - Prakiraan rega marang bathi|PRQR: Prakiraan rega marang bathi|CDXS - Pangali Forward P/E|Sangamo Therapeutics, Inc. (SGMO) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep NAUT|Rega marang bathi mangsa ngarep Metagenomi, Inc|Rasio prakiraan rega marang bathi Precision BioSciences Inc. DTIL|Rega marang bathi mangsa ngarep Generation Bio Co. (GBIO)|boundlessbio.com - Rasio rega marang bathi mangsa ngarep|Exicure - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi PHIO|Mustang Bio Corp - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi TransCode Therapeutics RNAZ|bionanogenomics.com (BNGO) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep APDN|BLUE (bluebird bio) - Pangali Forward P/E|Prakiraan rega marang bathi ImmunoPrecise (IPA)|Prakiraan rega marang bathi OMGA (Omega)|Kapitalisasi marang proyeksi bathi Singular Genomics Corp|Pangali Forward P/E RGLS (Regulus Therapeutics)|Kapitalisasi marang proyeksi bathi syros.com (SYRS)|TBIO - Rega marang bathi mangsa ngarep|TRACON Pharmaceuticals Inc. (TCON) - Prakiraan rega marang bathi|Unity Bio (UBX) - Rega marang bathi mangsa ngarep
